Protalix BioTherapeutics
PLX
#8687
Rank
A$0.25 B
Marketcap
A$3.11
Share price
1.42%
Change (1 day)
-23.59%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): A$11.65 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are A$61.84 Million. In 2024 the company made an earning of A$7.58 Million a decrease over its 2023 earnings that were of A$17.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$11.65 M53.6%
2024 A$7.58 M-55.62%
2023 A$17.1 M-199.05%
2022 -A$17.27 Million-40.38%
2021 -A$28.97 Million-732.31%
2020 A$4.58 M-130.53%
2019 -A$15.01 Million189.85%
2018 -A$5.18 Million-95.29%
2017 -A$0.11 Billion308.12%
2016 -A$26.94 Million-32.37%
2015 -A$39.83 Million10.11%
2014 -A$36.17 Million-7.59%
2013 -A$39.14 Million
2011 -A$45.32 Million-19.39%
2010 -A$56.23 Million20.87%
2009 -A$46.52 Million32.26%
2008 -A$35.17 Million-5.46%
2007 -A$37.2 Million
2004 -A$0.25 Million12.35%
2003 -A$0.22 Million-11.1%
2002 -A$0.25 Million-57.03%
2001 -A$0.57 Million1.03%
2000 -A$0.56 Million-53.22%
1999 -A$1.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.82 B 136,540.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.92 B 8,433.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.27 M-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.13 B 28,751.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel